Cliff Asness's FENC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 92,889 shares of Fennec Pharmaceuticals Inc. (FENC) worth $998,557, representing 0.00% of the portfolio. First purchased in 2018-Q2, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in FENC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 68,743 shares. Largest reduction occurred in Q4 2018, reducing 20,560 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Fennec Pharmaceuticals (FENC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fennec Pharmaceuticals (FENC) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +68,743 | Add 284.70% | 92,889 | $10.75 |
| Q1 2026 | +9,007 | Add 59.50% | 24,146 | $6.15 |
| Q4 2025 | +127 | Add 0.85% | 15,139 | $7.70 |
| Q3 2025 | +700 | Add 4.89% | 15,012 | $9.36 |
| Q2 2025 | +3,415 | Add 31.34% | 14,312 | $8.30 |
| Q1 2025 | +10,897 | New Buy | 10,897 | $6.09 |
| Q2 2021 | -12,977 | Sold Out | 0 | $0.00 |
| Q1 2021 | -3,614 | Reduce 21.78% | 12,977 | $6.24 |
| Q4 2020 | -5,168 | Reduce 23.75% | 16,591 | $7.47 |
| Q3 2020 | +21,759 | New Buy | 21,759 | $6.07 |
| Q4 2018 | -20,560 | Sold Out | 0 | $0.00 |
| Q3 2018 | +4,429 | Add 27.46% | 20,560 | $8.22 |
| Q2 2018 | +16,131 | New Buy | 16,131 | $10.41 |
Cliff Asness's Fennec Pharmaceuticals Investment FAQs
Cliff Asness first purchased Fennec Pharmaceuticals Inc. (FENC) in Q2 2018, acquiring 16,131 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Fennec Pharmaceuticals Inc. (FENC) for 13 quarters since Q2 2018.
Cliff Asness's largest addition to Fennec Pharmaceuticals Inc. (FENC) was in Q2 2026, adding 92,889 shares worth $998,557.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 92,889 shares of Fennec Pharmaceuticals Inc. (FENC), valued at approximately $998,557.
As of the Q2 2026 filing, Fennec Pharmaceuticals Inc. (FENC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Fennec Pharmaceuticals Inc. (FENC) was 92,889 shares, as reported at the end of Q2 2026.